Viridian Therapeutics, Inc. VRDN Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s common stock, shares, outstanding?
- Viridian Therapeutics, Inc. (VRDN) reported common stock, shares, outstanding of $102.46M in Q1 2026.
- How has Viridian Therapeutics, Inc.'s common stock, shares, outstanding changed year-over-year?
- Viridian Therapeutics, Inc.'s common stock, shares, outstanding increased by 25.6% year-over-year, from $81.59M to $102.46M.
- What is the long-term trend for Viridian Therapeutics, Inc.'s common stock, shares, outstanding?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s common stock, shares, outstanding has grown at a 88.9% compound annual growth rate (CAGR), from $4.23M to $101.83M.